Breaking down the barriers to cancer immunotherapy Journal Article
| Authors: | Pure, E.; Allison, J. P.; Schreiber, R. D. |
| Article Title: | Breaking down the barriers to cancer immunotherapy |
| Abstract: | Emerging insights into the mechanisms of activation and negative regulation of innate and adaptive immune cells are providing new opportunities for the development of safe and effective cancer vaccines. © 2005 Nature Publishing Group. |
| Keywords: | unclassified drug; clinical trial; drug efficacy; drug safety; nonhuman; conference paper; neoplasms; animals; cytotoxic t lymphocyte antigen 4 antibody; cancer immunotherapy; imiquimod; granulocyte macrophage colony stimulating factor; regulatory mechanism; immunotherapy; cancer vaccine; cpg oligodeoxynucleotide; tumor cell; innate immunity; cell activation; antibody; immunocompetent cell; alpha galactosylceramide; natural killer cell receptor nkg2d; adjuvant; denileukin diftitox; receptor antibody; immunity, natural |
| Journal Title: | Nature Immunology |
| Volume: | 6 |
| Issue: | 12 |
| ISSN: | 1529-2908 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2005-12-01 |
| Start Page: | 1207 |
| End Page: | 1210 |
| Language: | English |
| DOI: | 10.1038/ni1205-1207 |
| PUBMED: | 16369561 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 34" - "Export Date: 24 October 2012" - "CODEN: NIAMC" - "Source: Scopus" |
